See more : BOSA Technology Holdings Limited (8140.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Synairgen plc (SNG.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Synairgen plc, a leading company in the Biotechnology industry within the Healthcare sector.
- Advanced Health Limited (AVL.JO) Income Statement Analysis – Financial Results
- Montanaro UK Smaller Companies Investment Trust PLC (MTU.L) Income Statement Analysis – Financial Results
- EverGen Infrastructure Corp. (EVGN.V) Income Statement Analysis – Financial Results
- Donear Industries Limited (DONEAR.NS) Income Statement Analysis – Financial Results
- Epic Corp. (EPOR) Income Statement Analysis – Financial Results
Synairgen plc (SNG.L)
About Synairgen plc
Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease. The company has a licensing and collaboration agreement with Pharmaxis Ltd. to develop a LOXL2 inhibitor. Synairgen plc was incorporated in 2004 and is headquartered in Southampton, the United Kingdom.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 105.00 | 5.03K | 0.00 | 25.00 | 4.29K | 0.00 | 0.00 | 155.00K | 0.00 | 0.00 | 0.00 | 78.00K | 82.00K | 202.00K | 82.00K |
| Cost of Revenue | 84.00K | 102.00K | 195.00K | 260.00K | 163.00K | 0.00 | 0.00 | 28.00K | 31.00K | 0.00 | 0.00 | 0.00 | 43.00K | 0.00 | 0.00 | 0.00 | 33.00K | 15.00K | 135.00K | 18.00K |
| Gross Profit | -84.00K | -102.00K | -195.00K | -260.00K | -163.00K | 105.00 | 5.03K | -28.00K | -30.98K | 4.29K | 0.00 | 0.00 | 112.00K | 0.00 | 0.00 | 0.00 | 45.00K | 67.00K | 67.00K | 64.00K |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 0.00% | -123,900.00% | 100.00% | 0.00% | 0.00% | 72.26% | 0.00% | 0.00% | 0.00% | 57.69% | 81.71% | 33.17% | 78.05% |
| Research & Development | 6.53M | 14.93M | 52.85M | 15.49M | 3.45M | 3.23K | 2.06K | 2.40M | 1.36K | 1.65K | 1.29M | 1.51M | 2.91M | 2.11M | 2.11M | 2.00M | 1.52M | 1.08M | 557.00K | 123.00K |
| General & Administrative | 3.76M | 5.36K | 5.01K | 2.25K | 1.36K | 1.01K | 1.35K | 1.02M | 1.28K | 1.55K | 986.00K | 982.00K | 904.00K | 880.00K | 864.00K | 753.00K | 750.00K | 664.00K | 418.00K | 0.00 |
| Selling & Marketing | 0.00 | 5.27M | 4.82M | 1.99M | 1.21M | 0.00 | 0.00 | -9.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.76M | 5.27M | 4.82M | 2.00M | 1.21M | 1.01K | 1.35K | 1.01M | 1.28K | 1.55K | 986.00K | 982.00K | 904.00K | 880.00K | 864.00K | 753.00K | 750.00K | 664.00K | 418.00K | 0.00 |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 86.00K | 0.00 | 0.00 | 0.00 | -4.00K | 0.00 | 0.00 | -13.00K |
| Operating Expenses | 10.29M | 20.20M | 57.67M | 17.48M | 4.65M | 4.24K | 3.41K | 3.41M | 2.63K | 3.20K | 2.28M | 2.49M | 3.81M | 2.99M | 2.97M | 2.76M | 2.27M | 1.75M | 975.00K | 230.00K |
| Cost & Expenses | 10.29M | 20.30M | 57.87M | 17.74M | 4.82M | 4.24K | 3.41K | 3.44M | 2.63K | 3.20K | 2.28M | 2.49M | 3.85M | 2.99M | 2.97M | 2.76M | 2.31M | 1.76M | 1.11M | 248.00K |
| Interest Income | 635.00K | 207.00K | 11.00K | 19.00K | 30.00K | 36.00 | 14.00 | 38.00 | 50.00 | 31.00 | 11.00K | 27.00K | 35.00K | 71.00K | 130.00K | 291.00K | 342.00K | 376.00K | 298.00K | 13.00K |
| Interest Expense | 0.00 | 0.00 | 2.00K | 10.00K | 6.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -27.00K | 0.00 | -71.00K | 1.00K | 1.00K | 1.00K | 0.00 | 0.00 | 0.00 | |
| Depreciation & Amortization | 84.00K | 102.00K | 195.00K | 260.00K | 163.00K | 40.00K | 24.00K | 28.00K | 31.00 | 47.00 | 62.00K | 76.00K | 64.00K | 57.00K | 107.00K | 83.00K | 74.00K | 48.00K | 34.00K | 2.00K |
| EBITDA | -9.57M | -19.99M | -57.66M | -17.46M | -4.62M | -4.09M | 1.64M | -3.38M | -2.58M | 1.14M | -2.21M | -2.39M | -3.64M | -2.86M | -2.73M | -2.38M | -1.81M | -1.63M | -874.00K | -164.00K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,897.14% | 32.62% | 0.00% | -10,312.00% | 26.60% | 0.00% | 0.00% | -2,322.58% | 0.00% | 0.00% | 0.00% | -2,323.08% | -1,531.71% | -285.15% | -184.15% |
| Operating Income | -10.29M | -20.30M | -57.87M | -17.74M | -4.82M | -4.13K | 1.62K | -3.44M | -2.61K | 1.09K | -2.28M | -2.49M | -3.70M | -2.99M | -2.97M | -2.76M | -2.23M | -1.68M | -908.00K | -166.00K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,935.24% | 32.14% | 0.00% | -10,436.00% | 25.50% | 0.00% | 0.00% | -2,386.45% | 0.00% | 0.00% | 0.00% | -2,856.41% | -2,048.78% | -449.50% | -202.44% |
| Total Other Income/Expenses | 635.00K | 207.00K | 9.00K | 9.00K | 24.00K | 36.00K | 14.00K | 38.00K | 50.00K | 31.00K | 11.00K | 27.00K | 35.00K | 71.00K | 129.00K | 290.00K | 341.00K | 376.00K | 298.00K | 13.00K |
| Income Before Tax | -9.66M | -20.09M | -57.86M | -17.73M | -4.79M | -4.10K | 1.63K | -3.40M | -2.56K | 1.13K | -2.27M | -2.46M | -3.66M | -2.92M | -2.84M | -2.47M | -1.89M | -1.30M | -610.00K | -153.00K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,900.95% | 32.42% | 0.00% | -10,236.00% | 26.22% | 0.00% | 0.00% | -2,363.87% | 0.00% | 0.00% | 0.00% | -2,419.23% | -1,590.24% | -301.98% | -186.59% |
| Income Tax Expense | -1.25M | -2.45M | -9.19M | -3.82M | -908.00K | 795.00 | 132.00 | -587.00K | 304.00 | 63.00 | -224.00K | -213.00K | -433.00K | -368.00K | -348.00K | -315.00K | -247.00K | -255.00K | -298.00K | -13.00K |
| Net Income | -8.41M | -17.65M | -48.66M | -13.92M | -3.89M | -3.30K | 1.76K | -2.82M | -2.26K | 1.19K | -2.04M | -2.25M | -3.23M | -2.55M | -2.49M | -2.15M | -1.64M | -1.05M | -610.00K | -153.00K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,143.81% | 35.04% | 0.00% | -9,020.00% | 27.69% | 0.00% | 0.00% | -2,084.52% | 0.00% | 0.00% | 0.00% | -2,102.56% | -1,279.27% | -301.98% | -186.59% |
| EPS | -0.04 | -0.09 | -0.24 | -0.09 | -0.04 | -0.03 | 0.02 | -0.03 | -0.02 | 0.01 | -0.03 | -0.03 | -0.05 | -0.04 | -0.11 | -0.10 | -0.07 | -0.04 | -0.03 | -0.02 |
| EPS Diluted | -0.04 | -0.09 | -0.24 | -0.09 | -0.04 | -0.03 | 0.02 | -0.03 | -0.02 | 0.01 | -0.03 | -0.03 | -0.05 | -0.04 | -0.11 | -0.10 | -0.07 | -0.04 | -0.03 | -0.02 |
| Weighted Avg Shares Out | 201.38M | 201.36M | 200.44M | 147.12M | 110.09M | 95.26M | 94.18M | 91.90M | 91.32M | 88.00M | 75.64M | 72.47M | 60.56M | 60.10M | 23.57M | 21.82M | 24.24M | 23.78M | 18.84M | 10.14M |
| Weighted Avg Shares Out (Dil) | 201.38M | 201.36M | 200.44M | 147.12M | 110.09M | 95.26M | 94.24M | 91.90M | 91.32M | 88.18M | 75.64M | 72.47M | 60.56M | 60.10M | 23.57M | 21.82M | 24.24M | 23.78M | 18.84M | 10.14M |
Source: https://incomestatements.info
Category: Stock Reports